From March 24, 2024 to March 31, 2024, the company has repurchased 3,275,199 shares, representing 6.96% for $1,000 million. With this, the company has completed the repurchase of 3,275,199 shares, representing 6.96% for $1,000 million under the buyback announced on March 25, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
268.4 USD | -1.62% | -2.50% | +22.02% |
05-16 | United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing | MT |
05-14 | United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.02% | 12.11B | |
+51.84% | 63.85B | |
-2.26% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.28% | 26.52B | |
-21.49% | 18.69B | |
+2.76% | 12.73B | |
+27.58% | 12.07B | |
-10.05% | 11.19B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Tranche Update on United Therapeutics Corporation's Equity Buyback Plan announced on March 25, 2024.